The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
1,2-Didehydro-3-oxo-THCO (1,2-Didehydro-3-oxo-Δ8-tetrahydrocannabioctyl) is a semi-synthetic cannabinoid first synthesised by Raj K Razdan et al. in the 1970s, with potent cannabinoid effects.[1][2][3]
^Razdan RK, Dalzell HC, Herlihy P, Howes JF (November 1976). "Hashish. Unsaturated side-chain analogues of delta8-tetrahydrocannabinol with potent biological activity". Journal of Medicinal Chemistry. 19 (11): 1328–30. doi:10.1021/jm00233a014. PMID1003411.
^Razdan RK (January 1981). "The Total Synthesis of Cannabinoids.". In ApSimon J (ed.). Total Synthesis of Natural Products. Vol. 4. John Wiley & Sons. pp. 185–262. doi:10.1002/9780470129678.ch2. ISBN978-0-470-12953-1.
^US 4036857, Razdan RK, Dalzell HC, "Benzopyrans having an unsaturated side chain.", issued 19 July 1977, assigned to Sharps Associates